We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovative Retraction Device Lessens Damage to Brain Tissue

By HospiMedica International staff writers
Posted on 25 Mar 2010
A novel neurosurgery device offers a less invasive way to access cerebral surgical locations and perform critical procedures, with minimal damage to surrounding brain tissue.

The ViewSite Brain Access System (VBAS) consists of an introducer and a working channel port that allows the surgeon a seamless entry to the targeted site, while distributing brain tissue evenly in a 360° dispersion pattern. More...
The ample working channel allows multiple instruments to be used simultaneously, while providing an excellent depth of view of the site as well as the brain wall. Among the added benefits are superior binocular vision to see in and around the surgical site; multiple sizes in different widths and lengths to meet all surgical needs; and compatibility with most surgical arms to avoid accidental displacement or movement during surgery. The VBAS is available in four widths – 12 mm, 17 mm, 21 mm, and 28 mm, as well as three different lengths – 3 cm, 5 cm, and 7 cm.

The VBAS transcortical (TC) model can be used in any cranial procedure that is intraventricular or subcortical in nature, and is designed for use in intracerebral hematomas, arteriovenous malformations (AVM), cavernous malformations, metastatic and primary brain tumors, cerebral cysts, intra-axial tumors and lesions, and intraventricular tumors. The TC model eliminates brain shift, allowing for straight path to the target without lateral displacement of the brain or target. For each centimeter of depth of placement, the amount of brain displacement is far less with the TC device than would be required with standard retraction. The ViewSite Brain Access System and the VBAS transcortical (TC) model are products of Vycor Medical (Bohemia, NY, USA).

"The ViewSite Brain Access System provides a minimally traumatic surgical corridor to deep seated brain tumors, resulting in effective and efficient tumor removal with minimal morbidity,” said Michael Weaver, M.D., an assistant professor of neurosurgery at Temple University (Philadelphia, PA, USA). "I have been extremely pleased with the results of the surgeries I have performed with the ViewSite.”

Related Links:

Vycor Medical



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.